NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 174 filers reported holding NEVRO CORP in Q4 2016. The put-call ratio across all filers is 0.56 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $2,674,000 | -31.8% | 68,760 | 0.0% | 0.11% | -19.7% |
| Q3 2018 | $3,919,000 | -7.4% | 68,760 | +29.8% | 0.14% | -11.8% |
| Q2 2018 | $4,231,000 | -7.9% | 52,990 | 0.0% | 0.16% | -10.1% |
| Q1 2018 | $4,593,000 | -65.8% | 52,990 | -72.8% | 0.18% | -65.4% |
| Q4 2017 | $13,437,000 | -24.0% | 194,621 | 0.0% | 0.52% | -18.0% |
| Q3 2017 | $17,687,000 | +22.1% | 194,621 | 0.0% | 0.63% | +17.7% |
| Q2 2017 | $14,486,000 | +455.0% | 194,621 | +678.5% | 0.54% | +437.0% |
| Q3 2016 | $2,610,000 | -28.9% | 25,000 | -49.8% | 0.10% | -33.3% |
| Q2 2016 | $3,673,000 | +31.1% | 49,800 | 0.0% | 0.15% | +26.1% |
| Q1 2016 | $2,802,000 | +66.0% | 49,800 | +99.2% | 0.12% | +95.1% |
| Q4 2015 | $1,688,000 | – | 25,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 562,833 | $40,710,000 | 4.84% |
| Altium Capital Management LP | 77,000 | $5,569,000 | 1.86% |
| PFM Health Sciences, LP | 649,513 | $46,979,000 | 1.76% |
| Rock Springs Capital Management LP | 721,500 | $52,186,000 | 1.31% |
| Integral Health Asset Management, LLC | 50,000 | $3,617,000 | 0.94% |
| Redmile Group, LLC | 411,017 | $29,729,000 | 0.93% |
| K2 PRINCIPAL FUND, L.P. | 114,800 | $8,303,000 | 0.72% |
| Connacht Asset Management LP | 18,762 | $1,357,000 | 0.70% |
| Perceptive Advisors | 477,037 | $34,504,000 | 0.69% |
| ArrowMark Colorado Holdings LLC | 855,439 | $61,874,000 | 0.54% |